Citations 1
Relationship between level of PD-L1 expression and outcomes in the KEYNOTE-010 study of pembrolizumab vs docetaxel for previously treated, PD-L1–Positive NSCLC.
Baas, Paul, Molina, Julian R. , Kim, Joo-Hang , Arvis, Catherine Dubos, Ahn, Myung‐Ju , Fidler, Mary J. , Castro, Gilberto de , Garrido, Marcelo , Shentu, Yue , Lubiniecki, Gregory M., Im, Ellie, Baas, Paul, Garon, Edward B. , Herbst, Roy S. , Felip, Enriqueta , Perez‐Gracia, José Luis , Han, Ji-Youn , Majem, Margarita , Barlési, Fabrice , Kim, Dong‐Wan
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 9015-9015
